Key facts
- It has raised $3.2M across 5 recorded rounds; the latest was Seed Round ($350K) in Jan 2026.
- Notable investors include National Institutes of Health, Illinois Ventures, Ideaship, U.S. Department of Health and Human Services.
- Siloam Vision has filed 5 Form Ds with the SEC since 2025, most recently Jan 2026 ($350K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Siloam Vision
Funding rounds
5 roundsAbout Siloam Vision
Developer of a comprehensive eye care platform designed to reduce preventable blindness and improve population health worldwide. The company offers AI-powered diagnostic tools, wide-field retinal imaging devices, and collaborative care software, enabling healthcare providers in underserved regions to detect and manage vision-threatening diseases at early stages.
- Sector
- Healthcare
- HQ
- Portland, OR, United States
- Founded
- 2021
- Employees
- 8
- Website
- siloamvision.com/
- Ownership
- Privately Held (backing)
Siloam Vision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Siloam Vision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Siloam Vision in its N-PORT filings yet. We sweep new filings monthly.